Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Christina Lake Cannabis Corp

Healthcare US CLCFF

0.023USD
0.00(0%)

Last update at 2026-06-18T20:00:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.05
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap6.20M
  • Volume12000
  • P/E Ratio2.50
  • Dividend Yield-%
  • EBITDA3.67M
  • Revenue TTM15.08M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM 7.01M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Type yearly yearly yearly yearly yearly
Date 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Income before tax 0.86M -4.13183M -2.02772M -7.14295M 0.94M
Minority interest - - - - -
Net income 0.86M -4.13183M -2.02772M -7.14295M -2.85264M
Selling general administrative 5.52M 4.06M 3.93M 4.74M 5.00M
Selling and marketing expenses - - - - -
Gross profit 9.31M 3.61M 2.98M 0.06M 4.77M
Reconciled depreciation 0.45M 0.43M 0.33M 0.34M 0.14M
Ebit - - - -5.03819M -0.27688M
Ebitda - - -0.93892M -5.96558M 1.65M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 3.10M -1.10810M -1.44041M -5.09719M -5.16767M
Other operating expenses - - - 0.01M 0.03M
Interest expense 1.94M 1.08M 0.76M 0.84M 0.57M
Tax provision - - - - -
Interest income 0.05M 0.01M - - -
Net interest income -1.89557M -1.06268M -0.75977M -0.84116M -0.57238M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 13.61M 11.78M 10.07M 3.63M 0.00000M
Total operating expenses 10.51M 12.89M 11.51M 8.73M 5.17M
Cost of revenue 4.30M 8.17M 7.09M 3.58M -4.76720M
Total other income expense net -0.33877M -1.96105M 0.17M -1.20460M 6.68M
Discontinued operations - - - - -
Net income from continuing ops 0.86M -4.13183M -2.02772M -7.14295M 0.94M
Net income applicable to common shares - - - -7.14295M -2.85264M
Preferred stock and other adjustments - - - - -
Breakdown 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Type yearly yearly yearly yearly yearly
Date 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Total assets 23.37M 15.96M 18.79M 18.97M 17.80M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 12.57M 8.50M 7.66M 9.23M 8.35M
Total stockholder equity 10.79M 7.46M 11.14M 9.74M 9.46M
Deferred long term liab - - - - -
Other current liab - - - 3.06M 1.11M
Common stock - - - 19.46M 11.74M
Capital stock 24.37M 22.50M 22.40M 19.46M 11.74M
Retained earnings -17.44843M -18.48199M -15.99348M -12.95306M -5.81011M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 1.80M 1.47M 1.81M 1.08M 1.84M
Cash and equivalents - - - - -
Total current liabilities 6.27M 4.00M 5.83M 7.39M 1.82M
Current deferred revenue - - - - -
Net debt 8.05M 4.68M 4.64M 2.73M 2.18M
Short term debt - - - - -
Short long term debt 3.84M 1.66M 4.62M 3.77M 0.00391M
Short long term debt total - - - - -
Other stockholder equity - - - 3.23M 3.53M
Property plant equipment - - - 9.54M 9.53M
Total current assets 13.84M 10.01M 9.52M 9.42M 8.27M
Long term investments - - - - -
Net tangible assets - - - 9.74M 9.46M
Short term investments 0.05M 0.00000M 0.03M - -
Net receivables 1.56M 1.85M 1.91M 1.07M 0.07M
Long term debt 6.02M 4.50M 1.82M 0.04M 4.02M
Inventory 10.24M 5.65M 5.77M 7.15M 6.22M
Accounts payable 0.61M 0.56M 0.49M 0.29M 0.23M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 9.53M 5.95M 9.28M 9.54M 9.53M
Capital lease obligations 0.41M 0.00000M 0.00000M 0.00465M 0.03M
Long term debt total - - - - -
Breakdown 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Type yearly yearly yearly yearly yearly
Date 2024-11-30 2023-11-30 2022-11-30 2021-11-30 2020-11-30
Investments -0.12071M 0.03M -0.79041M -1.20469M -4.78298M
Change to liabilities - - - 0.10M 0.61M
Total cashflows from investing activities - - - -1.20469M -4.78298M
Net borrowings 2.72M -1.15282M - -0.03511M 3.95M
Total cash from financing activities 4.59M -1.15282M 0.37M 5.06M 9.20M
Change to operating activities - - - 0.00721M -0.12383M
Net income 0.86M -4.13183M -2.02772M -7.14295M -2.85264M
Change in cash 0.34M -0.34261M 0.76M -0.76869M 1.10M
Begin period cash flow 1.47M 1.81M 1.05M 1.84M 0.74M
End period cash flow 1.80M 1.47M 1.81M 1.08M 1.84M
Total cash from operating activities 0.22M 1.38M 1.18M -4.62058M -3.31685M
Issuance of capital stock 1.87M 0.00000M 0.00000M 3.62M 4.16M
Depreciation 0.45M 0.43M 0.33M 0.34M 0.14M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.54548M 0.32M -1.26256M -2.27498M -1.25380M
Change to account receivables - - - -1.00071M 0.11M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -0.02612M
Change to netincome - - - 5.35M 0.06M
Capital expenditures 4.35M 0.60M 0.79M 1.23M 4.78M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02966M 1.05M -1.63347M -3.16777M -0.66346M
Stock based compensation 0.00415M 0.08M 0.38M 1.16M 2.37M
Other non cash items -1.06638M 1.33M 1.96M 0.33M -2.31404M
Free cash flow -4.13139M 0.78M 0.39M -5.84977M -8.09984M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLCFF
Christina Lake Cannabis Corp		 - -% 0.02 2.50 - 0.41 0.51 1.07 4.47
ZTS
Zoetis Inc		 -2.82 3.58% 75.89 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 - -% 42.94 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is based in Vancouver, Canada.

Christina Lake Cannabis Corp

1075 West Georgia Street, Vancouver, BC, Canada, V6E 3C9

Key Executives

Name Title Year Born
Mr. Rob Jones Pres NA
Mr. Ryan James Smith Chief Financial Officer NA
Mr. Nicco Dehaan COO & Director NA
Mr. Timothy O'Donnell Head of Extraction NA
Mr. Salvatore Milia Head of R&D and Independent Director NA
Mr. Raymund Baterina Corp. Sec. NA
Mr. Mark Aiken Chief Exec. Officer NA
Mr. Milan Stefancik Director of Sales & Marketing NA
Mr. Mark Aiken Chief Executive Officer NA
Mr. Salvatore Milia Head of R&D and Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.